0001752724-22-202559.txt : 20220909 0001752724-22-202559.hdr.sgml : 20220909 20220909103657 ACCESSION NUMBER: 0001752724-22-202559 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220909 DATE AS OF CHANGE: 20220909 EFFECTIVENESS DATE: 20220909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KOREA FUND INC CENTRAL INDEX KEY: 0000748691 IRS NUMBER: 133226146 STATE OF INCORPORATION: MD FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-04058 FILM NUMBER: 221235297 BUSINESS ADDRESS: STREET 1: JPMORGAN ASSET MANAGEMENT STREET 2: 60 VICTORIA EMBANKMENT CITY: LONDON STATE: X0 ZIP: EC4Y 0JP BUSINESS PHONE: 212-739-3000 MAIL ADDRESS: STREET 1: JPMORGAN ASSET MANAGEMENT STREET 2: 60 VICTORIA EMBANKMENT CITY: LONDON STATE: X0 ZIP: EC4Y 0JP N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000748691 XXXXXXXX 811-04058 true false false N-2 KOREA FUND INC 811-04058 0000748691 549300M4Y1IG0WPTKC03 60 Victoria Embankment London EC4Y 0JP GB 1-866-706-0510 JPMorgan Chase Bank, N.A. 383 Madison Avenue New York 10179 212-270-6000 Records relating to its functions as sub-administrator and fund accounting agent JPMorgan Asset Management (Asia Pacific) Limited 21st Floor, Charter House 8 Connaught Road Central Hong Kong HK 999077 201-595-6242 Records related to its function as investment manager. American Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn 11219 718-921-8200 Records related to its functions as transfer agent and shareholder service agent. JPMorgan Funds Limited 60 Victoria Embankment London GB EC4Y 0JP 212-739-3000 Records related to its function as administrator. JPMorgan Chase Bank, N.A. 4 Chase Metrotech Center Brooklyn 11245 718-242-0609 Records relating to its functions as custodian N N N N-2 Y Madam Yan Hu 000000000 N Julian Reid 000000000 N Richard A. Silver 000000000 N Matthew J. Sippel 000000000 N Stephen M. Ungerman 002315698 277 Park Avenue New York 10172 XXXXXX N N N N N N N PricewaterhouseCoopers LLP 238 5493002GVO7EO8RNNS37 N N N N N N N KOREA FUND INC 549300M4Y1IG0WPTKC03 N 0 0 0 N/A Y N Y N Goldman Sachs Bank USA KD3XUN7C6T14HNAYLU02 N N Revenue sharing split 0.00000000 0.00000000 Rule 23c-1 (17 CFR 270.23c-1) Rule 32a-4 (17 CFR 270.32a-4) N N N N JPMorgan Asset Management (Asia Pacific) Limited 801-114775 000300114 5493006DKST2MXVG4R57 HK N American Stock Transfer & Trust Company, LLC 084-00416 254900TS5EWP83BEOU02 N N N Refinitiv Global Markets Inc. 000109120 CRD N N Euroclear 549300OZ46BRLZ8Y6F65 BE N Y Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7) JPMorgan Chase Bank, N.A. 7H6GLXDRUGQFU57RNE97 Y N Self - rule 17f-2 (17 CFR 270.17f-2) Mizuho Bank, Ltd. RB0PEZSDGCO3JS6CEU02 JP N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) JPMorgan Chase Bank, N.A. 7H6GLXDRUGQFU57RNE97 GB Y Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) Standard Chartered Bank Korea Limited NUXTG47HHHM1K2L0SG39 KR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N American Stock Transfer & Trust Company, LLC 254900TS5EWP83BEOU02 N N N JPMorgan Funds Limited 549300AV3Y6VMWJUXJ60 GB Y N JPMorgan Chase Bank, N.A. 7H6GLXDRUGQFU57RNE97 Y Y N KBFG Securities America Inc. 8-48651 000039356 988400YEJH0X5UFGA795 9871.70000000 Credit Suisse Securities (USA) LLC 8-00422 000000816 1V8Y6QCX6YMJ2OELII46 23986.19000000 Daiwa Capital Markets America Inc. 8-12242 000001576 M67H5PRC0NQKM73ZAS82 6472.90000000 Credit Agricole Securities (USA) Inc. 8-13753 000000190 549300WO2DKF0Q3YMV43 9200.30000000 NH Investment & Securities America, Inc. 8-45081 000030660 254900F5AHZN93LET054 21129.17000000 Merrill Lynch, Pierce, Fenner & Smith Inc. 8-07221 000007691 8NAV47T0Y26Q87Y0QP81 9293.23000000 Samsung Securities (America), Inc. 8-50272 000043432 894500606BA4B4TM5W91 4460.70000000 Macquarie Capital (USA) Inc. 8-47198 000036368 549300670K07JRB5UQ40 11699.98000000 Korea Investment & Securities America, Inc. 8-52615 000104158 254900BQWCLQ4WNPW537 49907.99000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 12238.11000000 168439.22000000 Credit Suisse Securities (USA) LLC 8-00422 000000816 1V8Y6QCX6YMJ2OELII46 802802.45000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 1651590.22000000 2454392.67000000 N 209582387.01000000 Common stock Korea Fund, Inc. N N Common stock N N N 0.70000000 1.21000000 24.35000000 28.54000000 false false true false false false false false false false false INTERNAL CONTROL RPT 2 d361611dex11.htm FOR VALIDATION PURPOSES ONLY - [361611.TX]

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of The Korea Fund, Inc.

In planning and performing our audit of the financial statements of The Korea Fund, Inc. (the “Fund”) as of and for the year ended June 30, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund’s internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and directors of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the fund’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of June 30, 2022.

 

PricewaterhouseCoopers LLP, PricewaterhouseCoopers Center, 300 Madison Avenue, New York, NY 10017

T: (646) 471 3000, www.pwc.com/us

This report is intended solely for the information and use of the Board of Directors of The Korea Fund, Inc. and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ PricewaterhouseCoopers LLP

New York, New York

August 26, 2022

 

                    2